drugset / Trial / NCT04968158

Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain

NCT04968158

Phase 3 Completed 124 enrolled Laboratorios Silanes S.A. de C.V.
RandomizedParallel-groupOpen-labelTreatment

Summary

Phase IIIb, longitudinal, multicenter, randomized, open-label clinical trial to evaluate the efficacy and safety of the fixed-dose combination of etoricoxib 90 mg and tramadol 50 mg compared with fixed-dose therapy of acetaminophen 325 mg and tramadol 37.5 mg for the management of acute low back pain.

Timeline

Start
2021-11-29
Primary completion
2022-03-15
Completion
2022-04-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 325 mg Oral
Subject Etoricoxib Small molecule 90 mg Oral
Comparator Tramadol Other / unclassified 37.5 mg Oral
Comparator Tramadol Other / unclassified 50 mg Oral

Indications

No indication recorded.